• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型载药凝胶核心脂质体的研制及其作为传播阻断疟疾疫苗的特性。

Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine.

机构信息

Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, MP 470003, India.

出版信息

J Control Release. 2009 Dec 3;140(2):157-65. doi: 10.1016/j.jconrel.2009.08.004. Epub 2009 Aug 15.

DOI:10.1016/j.jconrel.2009.08.004
PMID:19686788
Abstract

The aim of present work was to investigate the potential utility of novel carrier gel core liposomes for intramuscular delivery of transmission blocking malaria antigen Pfs25 and to evaluate the effect of co-administration of vaccine adjuvant CpGODN on immune enhancement of recombinant protein antigen Pfs25. In the present work we have prepared gel core liposomes containing core of biocompatible polymer poly acrylic acid in phospholipid bilayer by reverse phase evaporation method and characterized for various in vitro parameters. In process stability of the encapsulated antigen was evaluated by SDS-PAGE followed by western blotting. The immune stimulating ability was studied by measuring anti-Pfs25 antibody titer in serum of Balb/c mice following intramuscular administration of various formulations. A Significant and perdurable immune responses was obtained after intramuscular administration of gel core liposomes encapsulated Pfs25 as compared to Pfs25 loaded conventional liposomes. Moreover co-administration of CpGODN in liposomes (conventional and gel core) was found to further increase the immunogenicity of vaccine. The result indicates high potential of gel core liposomes for their use as a carrier adjuvant for intramuscular delivery of recombinant antigen Pfs25 based transmission blocking malaria vaccine.

摘要

本研究旨在探索新型载体制剂凝胶芯脂质体作为肌肉内传递传播阻断性疟疾抗原 Pfs25 的潜在应用,并评估疫苗佐剂 CpGODN 共同给药对重组蛋白抗原 Pfs25 免疫增强的影响。在本工作中,我们通过反相蒸发法制备了含有生物相容性聚合物聚丙烯酸核的凝胶芯脂质体,并对其进行了各种体外参数的表征。通过 SDS-PAGE 结合 Western blot 评估了包封抗原的过程稳定性。通过测量 Balb/c 小鼠肌肉内给予各种制剂后血清中的抗 Pfs25 抗体滴度来研究其免疫刺激能力。与负载 Pfs25 的传统脂质体相比,肌肉内给予凝胶芯脂质体包封的 Pfs25 后可获得显著且持久的免疫应答。此外,CpGODN 在脂质体(传统和凝胶芯)中的共同给药被发现进一步增加了疫苗的免疫原性。结果表明,凝胶芯脂质体具有作为基于肌肉内传递的重组抗原 Pfs25 的传播阻断性疟疾疫苗的载体佐剂的高潜力。

相似文献

1
Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine.新型载药凝胶核心脂质体的研制及其作为传播阻断疟疾疫苗的特性。
J Control Release. 2009 Dec 3;140(2):157-65. doi: 10.1016/j.jconrel.2009.08.004. Epub 2009 Aug 15.
2
Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.用一种疟疾传播阻断候选疫苗Pfs25进行鼻腔免疫,可在小鼠中诱导出针对恶性疟原虫野外分离株的完全保护性免疫。
Infect Immun. 2005 Nov;73(11):7375-80. doi: 10.1128/IAI.73.11.7375-7380.2005.
3
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.通过将Pfs25与IMX313多聚化技术融合来增强疟疾疫苗的免疫原性和传播阻断活性。
Sci Rep. 2016 Jan 8;6:18848. doi: 10.1038/srep18848.
4
Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.CpG 寡脱氧核苷酸对恶性疟原虫传播阻断疫苗抗原 Pfs25 免疫原性的影响。
Infect Immun. 2004 Jan;72(1):584-8. doi: 10.1128/IAI.72.1.584-588.2004.
5
Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose.基于粒子的、PfS230 和 PfS25 免疫接种是有效的,但在固定总抗原剂量下不会因双效而改善。
Malar J. 2020 Aug 28;19(1):309. doi: 10.1186/s12936-020-03368-5.
6
Poor CD4 T Cell Immunogenicity Limits Humoral Immunity to Transmission-Blocking Candidate Pfs25 in Humans.CD4 T 细胞免疫原性差限制了对人类传播阻断候选 Pfs25 的体液免疫。
Front Immunol. 2021 Sep 30;12:732667. doi: 10.3389/fimmu.2021.732667. eCollection 2021.
7
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.用与人用兼容的强效佐剂配制的藻类产生的疟疾传播阻断疫苗候选物Pfs25可诱导高亲和力抗体,这些抗体可阻断恶性疟原虫对蚊子的感染。
Infect Immun. 2015 May;83(5):1799-808. doi: 10.1128/IAI.02980-14. Epub 2015 Feb 17.
8
Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles.使用恶性疟原虫抗原Pfs25附着的金纳米颗粒的疟疾纳米疫苗。
Vaccine. 2015 Sep 22;33(39):5064-71. doi: 10.1016/j.vaccine.2015.08.025. Epub 2015 Aug 20.
9
Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.通过体内电穿孔显著增强基于Pfs25 DNA的疟疾传播阻断疫苗的免疫原性。
Vaccine. 2008 Jan 10;26(2):185-92. doi: 10.1016/j.vaccine.2007.10.066. Epub 2007 Nov 20.
10
A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.一种新型植物生产的Pfs25融合亚单位疫苗可诱导持久的传播阻断抗体反应。
Hum Vaccin Immunother. 2015;11(1):124-32. doi: 10.4161/hv.34366. Epub 2014 Nov 1.

引用本文的文献

1
Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria.疟疾治疗与控制的当前挑战及基于纳米技术的药物策略
Parasite Epidemiol Control. 2022 Feb 16;17:e00244. doi: 10.1016/j.parepi.2022.e00244. eCollection 2022 May.
2
Preparation, characterization, and evaluation of eosin B-loaded nano-liposomes for growth inhibition of Plasmodium falciparum.载伊文思蓝纳米脂质体的制备、表征及其对恶性疟原虫生长抑制作用的评价。
Parasitol Res. 2022 Jan;121(1):383-393. doi: 10.1007/s00436-021-07395-2. Epub 2022 Jan 6.
3
Gel-Based Materials for Ophthalmic Drug Delivery.
用于眼科药物递送的凝胶基材料。
Gels. 2021 Aug 29;7(3):130. doi: 10.3390/gels7030130.
4
Liposomes for malaria management: the evolution from 1980 to 2020.脂质体用于疟疾管理:1980 年至 2020 年的发展历程。
Malar J. 2021 Jul 27;20(1):327. doi: 10.1186/s12936-021-03858-0.
5
Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines.利用脂质体疫苗诱导疟原虫特异性免疫应答。
Front Immunol. 2019 Feb 1;10:135. doi: 10.3389/fimmu.2019.00135. eCollection 2019.
6
Strategies & recent development of transmission-blocking vaccines against .针对……的传播阻断疫苗的策略与近期进展
Indian J Med Res. 2016 Jun;143(6):696-711. doi: 10.4103/0971-5916.191927.
7
The Use of Synthetic Carriers in Malaria Vaccine Design.合成载体在疟疾疫苗设计中的应用。
Vaccines (Basel). 2015 Oct 29;3(4):894-929. doi: 10.3390/vaccines3040894.
8
Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation.用于骨关节炎无创治疗的新型自组装凝胶核透明质体:体外优化、离体及体内渗透
Pharm Res. 2015 Sep;32(9):2901-11. doi: 10.1007/s11095-015-1672-8. Epub 2015 Mar 17.
9
Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery.整合素配体标记脂质体介导的 siRNA 递送至视网膜色素上皮细胞中对 VEGF 的高效下调。
Int J Nanomedicine. 2013;8:2613-27. doi: 10.2147/IJN.S39622. Epub 2013 Jul 22.
10
Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response.单次剂量微粒子传递疟疾传播阻断疫苗可引发持久的功能性抗体应答。
Curr Mol Med. 2013 May;13(4):479-87. doi: 10.2174/1566524011313040002.